Inspection and Regulation

17.01.19

Patient groups in appraisals of NHS drugs receiving undeclared funds from manufacturers, review finds

Two-thirds of patient groups involved in the appraisal of drugs and treatments for use in the NHS received money from the manufacturer or a competitor that they had not declared, according to new research.

The team behind the review is calling for stronger policy on disclosure and greater transparency from patient organisations and manufacturers to ensure that healthcare decisions are not unduly influenced by industry.

Patient groups are involved in the assessment of new medicines and treatments in the NHS, known as technology appraisal, and are asked to give their views when the National Institute for Health and Care Excellence (NICE) is deciding whether to approve a treatment for NHS use.

The review, carried out by scientists from the London School of Hygiene and Tropical Medicine and published in the British Medical Journal, said whilst patient involvement in decisions is “essential to an accurate and fair assessment” of new technologies, potential bias must be taken into account.

The team assessed 53 patient organisations which contributed to 41 NICE technology appraisals published between 2015 and 2016, and said that whilst some groups were transparent, others refused to help.

They found that 38 out of the 53 patient groups “held specific interests”, which means they received funding from manufacturers or competitors of a technology under appraisal, and were present on 79% of occasions that groups contributed to appraisals.

But the results also showed that NICE’s committees were aware of less than a quarter of these specific interests, and, as disclosure by patient groups is not required under current policy as it is in France, nearly two-thirds of the specific interests go unknown and risk affecting major industry decisions.

Dr Kate Mandeville, lead author from the London School of Hygiene and Tropical Medicine, commented: “NICE needs to urgently strengthen its disclosure policy for patient organisations to reassure the public that drug decisions are not unduly influenced by industry.”

“It is essential that patients can contribute to decisions over which new drugs should be made available on the NHS. Patients’ perspectives give important information on the impact of the condition and lead to better decisions.”

She called NICE a pioneer in involving patients in drug decisions, but found that its disclosure policy does not provide decision makers with enough information on funding received to make a valid assessment of treatments.

NICE said it knew patient groups received funding but “were not aware of the extent of these interests,” adding that it had already started looking into reviewing its policy using the review’s recommendations.

Image credit - SolStock

Comments

There are no comments. Why not be the first?

Add your comment

 

national health executive tv

more videos >

latest healthcare news

NHS pays £35m in tax penalties for staff breaching pension limits

21/02/2019NHS pays £35m in tax penalties for staff breaching pension limits

Nearly £35m was paid by the NHS for thousands of staff members who broke limits on pensions savings, according to the Financial Times.... more >
University Hospitals Plymouth NHS Trust hospital hit with ‘requires improvement’ rating again by CQC

21/02/2019University Hospitals Plymouth NHS Trust hospital hit with ‘requires improvement’ rating again by CQC

The health inspectorate has told University Hospitals Plymouth NHS Trust that it must improve its diagnostic and pharmacy services at Derriford H... more >
Suicidal NHS employee unfairly dismissed after being issued with ‘appalling’ legal threat by trust

20/02/2019Suicidal NHS employee unfairly dismissed after being issued with ‘appalling’ legal threat by trust

An NHS staff member was threatened with legal action by an ambulance trust after he reported feeling suicidal and was unfairly dismissed, an empl... more >

editor's comment

25/09/2017A hotbed of innovation

This edition of NHE comes hot on the heels of this year’s NHS Expo which, once again, proved to be a huge success at Manchester Central. A number of announcements were made during the event, with the health secretary naming the second wave of NHS digital pioneers, or ‘fast followers’, which follow the initial global digital e... read more >

last word

Hard to be optimistic

Hard to be optimistic

Rachel Power, chief executive of the Patients Association, warns that we must be realistic about the very real effects of continued underfunding across the health service. It’s now bey... more > more last word articles >

the scalpel's daily blog

Did Brexit drown out the NHS Long Term plan?

20/02/2019Did Brexit drown out the NHS Long Term plan?

In January the NHS released its much-anticipated Long Term plan, pledging to save 500,000 lives through new prevent strategies, and making a concerted effort to improve the general public’s health. But Simon Keen, media relations manager at NHS Providers, poses the question: Did Brexit drown out the NHS Long Term plan? Brexit. Bruss... more >
read more blog posts from 'the scalpel' >

comment

Maximising volunteer potential in hospitals

14/02/2019Maximising volunteer potential in hospitals

Sam Ward, director of commissioned services at the Royal Voluntary Service, argues that the right training can help harness the power of voluntee... more >
ICO: Cyber security and the NHS

14/02/2019ICO: Cyber security and the NHS

Peter Brown, acting head of technology policy at the Information Commissioner's Office (ICO), explains the importance of good practice in data pr... more >
Leading and managing experts

14/02/2019Leading and managing experts

A coaching conversation is likely to yield the best results. Managing experts in the health industry can be a challenging and varying responsibil... more >
Mesothelioma in the UK: a growing fight

14/02/2019Mesothelioma in the UK: a growing fight

The health impacts of asbestos in the UK can cast a much wider net than those in the construction and building sector. Liz Darlison, head of serv... more >

interviews

How can winter pressures be dealt with? Introduce a National Social Care Service, RCP president suggests

24/10/2018How can winter pressures be dealt with? Introduce a National Social Care Service, RCP president suggests

A dedicated national social care service could be a potential solution to surging demand burdening acute health providers over the winter months,... more >
RCP president on new Liverpool college building: ‘This will be a hub for clinicians in the north’

24/10/2018RCP president on new Liverpool college building: ‘This will be a hub for clinicians in the north’

The president of the Royal College of Physicians (RCP) has told NHE that the college’s new headquarters based in Liverpool will become a hu... more >
Duncan Selbie: A step on the journey to population health

24/01/2018Duncan Selbie: A step on the journey to population health

The NHS plays a part in the country’s wellness – but it’s far from being all that matters. Duncan Selbie, chief executive of Pu... more >
Cutting through the fake news

22/11/2017Cutting through the fake news

In an era of so-called ‘fake news’ growing alongside a renewed focus on reducing stigma around mental health, Paul Farmer, chief exec... more >

health service focus

View all News